These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 9434874)

  • 1. Intercellular communication, tumor promotion and non-genotoxic carcinogenesis: relationships based upon structural considerations.
    Rosenkranz M; Rosenkranz HS; Klopman G
    Mutat Res; 1997 Nov; 381(2):171-88. PubMed ID: 9434874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance of tests for cell transformation and gap-junction intercellular communication for detecting nongenotoxic carcinogenic activity.
    Swierenga SH; Yamasaki H
    IARC Sci Publ; 1992; (116):165-93. PubMed ID: 1428080
    [No Abstract]   [Full Text] [Related]  

  • 3. Epigenetic events during the process of cell transformation induced by carcinogens (review).
    Nguyen-Ba G; Vasseur P
    Oncol Rep; 1999; 6(4):925-32. PubMed ID: 10373683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Efficiency of evaluating the carcinogenicity of chemical substances in short-term tests and the SAR model].
    Tarasov VA; Tsarenko NA; Mel'nik VA; Mustafaev ON; Makedonov GP; Tarasov AV
    Genetika; 2009 Dec; 45(12):1674-84. PubMed ID: 20198980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of chemical structure on the extent and sites of carcinogenesis for 522 rodent carcinogens and 55 different human carcinogen exposures.
    Ashby J; Paton D
    Mutat Res; 1993 Mar; 286(1):3-74. PubMed ID: 7678908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salmonella mutagenicity and rodent carcinogenicity: quantitative structure-activity relationships.
    Blake BW; Enslein K; Gombar VK; Borgstedt HH
    Mutat Res; 1990 Jul; 241(3):261-71. PubMed ID: 2195334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of disrupted gap junctional intercellular communication in detection and characterization of carcinogens.
    Yamasaki H
    Mutat Res; 1996 Sep; 365(1-3):91-105. PubMed ID: 8898991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of structure-activity relationships and markers of cell toxicity to detect non-genotoxic carcinogens.
    Combes RD
    Toxicol In Vitro; 2000 Aug; 14(4):387-99. PubMed ID: 10906445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computer-aided analysis of mutagenicity and cell transformation data for assessing their relationship with carcinogenicity.
    Taningher M; Malacarne D; Perrotta A; Parodi S
    Environ Mol Mutagen; 1999; 33(3):226-39. PubMed ID: 10334625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A critical assessment of the methodologies to investigate the role of inhibition of apoptosis in rodent hepatocarcinogenesis.
    Sura R; Settivari RS; LeBaron MJ; Rowlands JC; Carney EW; Gollapudi BB
    Toxicol Mech Methods; 2015 Mar; 25(3):192-200. PubMed ID: 25608721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. International Commission for Protection Against Environmental Mutagens and Carcinogens. Approaches to SAR in carcinogenesis and mutagenesis. Prediction of carcinogenicity/mutagenicity using MULTI-CASE.
    Klopman G; Rosenkranz HS
    Mutat Res; 1994 Feb; 305(1):33-46. PubMed ID: 7508546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Guidelines for the evaluation of chemicals for carcinogenicity. Committee on Carcinogenicity of Chemicals in Food, Consumer Products and the Environment.
    Rep Health Soc Subj (Lond); 1991; 42():1-80. PubMed ID: 1763238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of non-genotoxic carcinogens and importance of a weight of evidence approach.
    Hernández LG; van Steeg H; Luijten M; van Benthem J
    Mutat Res; 2009; 682(2-3):94-109. PubMed ID: 19631282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The results of assays in Drosophila as indicators of exposure to carcinogens.
    Vogel EW; Graf U; Frei HJ; Nivard MM
    IARC Sci Publ; 1999; (146):427-70. PubMed ID: 10353398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nongenotoxic carcinogens: development of detection methods based on mechanisms: a European project.
    Yamasaki H; Ashby J; Bignami M; Jongen W; Linnainmaa K; Newbold RF; Nguyen-Ba G; Parodi S; Rivedal E; Schiffmann D; Simons JW; Vasseur P
    Mutat Res; 1996 Jun; 353(1-2):47-63. PubMed ID: 8692192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Global structure-activity relationship model for nonmutagenic carcinogens using virtual ligand-protein interactions as model descriptors.
    Cunningham AR; Carrasquer CA; Qamar S; Maguire JM; Cunningham SL; Trent JO
    Carcinogenesis; 2012 Oct; 33(10):1940-5. PubMed ID: 22678118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemical-induced transformation in BALB/c-3T3 cells: relationship between in vitro transformation and cytotoxicity, carcinogenesis, and genotoxicity.
    Matthews EJ
    Prog Clin Biol Res; 1990; 340D():229-38. PubMed ID: 2371296
    [No Abstract]   [Full Text] [Related]  

  • 18. International Commission for Protection Against Environmental Mutagens and Carcinogens. Application of SAR methods to non-congeneric data bases associated with carcinogenicity and mutagenicity: issues and approaches.
    Richard AM
    Mutat Res; 1994 Feb; 305(1):73-97. PubMed ID: 7508549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methods for predicting carcinogenic hazards: new opportunities coming from recent developments in molecular oncology and SAR studies.
    Taningher M; Malacarne D; Mancuso T; Peluso M; Pescarolo MP; Parodi S
    Mutat Res; 1997 Jun; 391(1-2):3-32. PubMed ID: 9219545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The mode of action of organic carcinogens on cellular structures.
    Luch A
    EXS; 2006; (96):65-95. PubMed ID: 16383015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.